BioNexus Gene Lab (BGLC) Accounts Payables (2018 - 2026)
BioNexus Gene Lab recorded quarterly Accounts Payables of $589700.0 in Q1 2026, up 46.83% quarter-over-quarter from $401611.0 in Q4 2025, and down 50.14% year-over-year from $1.2 million in Q1 2025.
BioNexus Gene Lab's Accounts Payables history runs 9 years deep, the most recent figure standing at $589700.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 50.14% year-over-year to $589700.0; the TTM figure through Mar 2026 stood at $589700.0 (down 50.14% YoY), while the FY2025 annual figure was $401611.0, up 41.36% from the prior year.
- Accounts Payables came in at $589700.0 for Q1 2026 at BioNexus Gene Lab, up from $401611.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $1.8 million in Q1 2022 to a low of $29776.0 in Q3 2023.
- A 5-year average of $564122.9 and a median of $292135.0 in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables soared 4693.16% in 2022 and slumped 97.95% in 2023, its largest moves.
- BioNexus Gene Lab's Accounts Payables stood at $103370.0 in 2022, then jumped by 1256.47% to $1.4 million in 2023, then tumbled by 79.74% to $284108.0 in 2024, then soared by 41.36% to $401611.0 in 2025, then soared by 46.83% to $589700.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $589700.0, $401611.0, and $184600.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 2.66 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 2.60 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 2.07 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 2.86 Bn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 4.00 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 2.54 Bn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 256.63 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 882.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 589,700.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 589,700.00 |
| Dec 31, 2025 | 401,611.00 |
| Sep 30, 2025 | 375,380.00 |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 284,108.00 |
| Sep 30, 2024 | 292,135.00 |
| Jun 30, 2024 | 169,883.00 |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 180,912.00 |
| Sep 30, 2023 | 29,776.00 |
| Jun 30, 2023 | 30,771.00 |
| Mar 31, 2023 | 37,550.00 |
| Dec 31, 2022 | 1.86 Mn |
| Sep 30, 2022 | 35,945.00 |
| Jun 30, 2022 | 1.42 Mn |
| Mar 31, 2022 | 1.83 Mn |
| Dec 31, 2021 | 71,814.00 |
| Sep 30, 2021 | 65,743.00 |
| Jun 30, 2021 | 34,884.00 |
| Mar 31, 2021 | 38,269.00 |
| Dec 31, 2020 | 1.03 Mn |
| Sep 30, 2020 | 6,452.00 |
| Jun 30, 2020 | 14,488.00 |
| Mar 31, 2020 | 16,592.00 |
| Dec 31, 2019 | 19,437.00 |
| Sep 30, 2019 | 7,582.00 |
| Mar 31, 2019 | 12,212.00 |
| Dec 31, 2018 | 11,149.00 |